IRIS
FAZIA, Maria Luigia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 875
EU - Europa 779
AS - Asia 416
Totale 2.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 873
UA - Ucraina 152
CN - Cina 145
SE - Svezia 121
IE - Irlanda 120
TR - Turchia 111
SG - Singapore 104
GB - Regno Unito 101
FR - Francia 92
IT - Italia 81
IN - India 51
DE - Germania 42
FI - Finlandia 27
RU - Federazione Russa 26
BE - Belgio 9
CZ - Repubblica Ceca 5
CA - Canada 2
IL - Israele 2
IR - Iran 2
NL - Olanda 2
NO - Norvegia 1
VN - Vietnam 1
Totale 2.070
Salva come PNG Salva come JPEG
Città #
Chandler 187
Jacksonville 150
Dublin 119
Singapore 89
Southend 70
Ashburn 56
Ann Arbor 54
Izmir 52
Princeton 50
Nanjing 36
Chieti 32
New York 30
Wilmington 29
Beijing 25
Cambridge 24
Altamura 21
Woodbridge 20
Dearborn 17
Washington 16
Nanchang 15
Santa Clara 15
Los Angeles 12
Boardman 10
Brussels 9
Tianjin 9
Kunming 7
Moscow 7
Auburn Hills 6
Grevenbroich 6
Hebei 5
Hefei 5
Shenyang 5
Augusta 4
Hangzhou 4
Norwalk 4
Orange 4
Zhengzhou 4
Brno 3
Foggia 3
Hanover 3
Jiaxing 3
Jinan 3
Lanzhou 3
Milan 3
Pescara 3
San Mateo 3
Seattle 3
Changsha 2
Guangzhou 2
Harbin 2
Helsinki 2
Kocaeli 2
Monmouth Junction 2
Ningbo 2
Rome 2
San Salvo 2
Taizhou 2
Toronto 2
Tortoreto 2
Ardabil 1
Binh Duong 1
Chongqing 1
Fairfield 1
Houston 1
Huizhou 1
Inveruno 1
Killorglin 1
Leawood 1
Mumbai 1
Nanning 1
Nanyang 1
Olomouc 1
Paris 1
Penne 1
Pontedera 1
Prague 1
Shijiazhuang 1
Simi Valley 1
Southgate 1
Totale 1.282
Salva come PNG Salva come JPEG
Nome #
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 119
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 116
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 109
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 103
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 99
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 96
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 95
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 88
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 87
Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk. 85
Novel determinants of plaque instability. 85
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 84
Association between 5-lipoxygenase expression and plaque instability in humans. 84
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 80
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 79
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 78
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 77
COX-2 expression in atherosclerosis: the good, the bad or the ugly? 75
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 70
Role of angiotensin II receptor blockers in atherosclerotic plaque stability. 69
COX-2 and atherosclerosis. 68
Enhanced soluble CD40 ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control 68
Fisiopatologia della placca aterosclerotica 66
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control 60
New insights on the molecular mechanisms of type-1 angiotensin II receptor blockers and their contribution to atherosclerotic plaque stabilization 58
Totale 2.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020181 0 0 0 0 0 16 38 34 12 28 48 5
2020/2021190 27 0 28 2 19 38 4 0 22 30 9 11
2021/2022128 5 1 2 33 11 2 6 7 8 9 15 29
2022/2023461 30 73 25 62 51 81 20 28 64 3 12 12
2023/2024235 12 6 26 2 21 98 45 4 3 4 1 13
2024/2025185 30 68 43 7 12 25 0 0 0 0 0 0
Totale 2.098